Skip Navigation

European Heart Journal 1997 18(Supplement A):125-133; doi:10.1093/eurheartj/18.suppl_A.125
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Iliceto, S.
Right arrow Articles by Eichstädt, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Iliceto, S.
Right arrow Articles by Eichstädt, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

How European cardiologists perceive the role of calcium antagonists in the treatment of heart failure and left ventricular dysfunction

S. Iliceto and H. Eichstädt*

University of Cagliari, Institute of cardiology Cagliari, Italy
* Virchow Klinikum, Strahlen und Poliklinik Berlin, Germany

Correspondence: Prof. Sabino Iliceto, Institute of Cardiology, University of Cagliari. Via S. Giorgio 12, 09100 Cagliari, Italy

In a poll of European cardiologists, one of the most popular of the given definitions of heart failure centres on the abnormality of ventricular function. However, opinion remains divided on the necessity of a distinction between diastolic and systolic heart failure, as it does on the value and procedures of stress testing.

The ‘no-reflow’ phenomenon continues to pose a challenge in conditions requiring myocardial reperfusion, and precise identification of some heart disorders apparently remains difficult in many cases.

Drug treatment of conditions like left ventricular dysfunction or arterial hypertension is open to continuing discussion, but calcium antagonists seem assured of an important role.

Key Words: Heart failure • left ventricular dysfunction • ‘no-reflow’ phenomenon • diagnostic imaging techniques • drug treatment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Postgrad. Med. J.Home page
A. Brodison, R. S More, and A. Chauhan
Stents in medicine: The role of coronary angioplasty and stenting in acute myocardial infarction
Postgrad. Med. J., October 1, 1999; 75(888): 591 - 598.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.